The Provider to Provider (Q7) Line was created in 2004 to provide a single phone number for community providers to reach a Seattle Children's specialist for educational information to ensure high-quality care for pediatric patients in the region.
Over time, the use of the Q7 line has changed and has served as a popular way for community providers to consult Children's specialists regarding the treatment of their patients. The line was never intended to provide consultative services and is no longer sustainable from an access, risk management, and provider workload perspective. As a result, the Q7 line will be discontinued.
Endocrinology will pilot discontinuation of the Q7 line beginning April 5. The line will be discontinued for all in fall 2024. Plans are being developed to support the line's discontinuation; more details will be shared in the coming months.
Call to Action:
- Clinical leaders: Share the planned discontinuation of the Q7 line with your applicable team members.
- Identify non-clinical team members you work with who may need to be aware of and share with them.
- Look for future communication on Q7 line discontinuation.
For more information please contact Shannon Stone